A randomized phase II study of radiation therapy, pemetrexed, and carboplatin with or without cetuximab in stage III non-small-cell lung cancer

被引：13

作者：

Bogart, Jeffrey A.

Govindan, Ramaswamy

机构：

[1] Washington Univ, Sch Med, Div Med Oncol, St Louis, MO 63110 USA

[2] Upstate Med Univ, Dept Radiat Oncol, Syracuse, NY USA

来源：

CLINICAL LUNG CANCER | 2006年 / 7卷 / 04期

关键词：

chemoradiation therapy; epidermal growth factor receptor; tyrosine kinase;

D O I：

10.3816/CLC.2006.n.009

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：285 / 287

页数：3

共 28 条

[1]

Blackstock AW, 2005, J CLIN ONCOL, V23, p635S

[2]

Bonner JA, 2004, J CLIN ONCOL, V22, p489S

[3]

Bradley JD, 2005, J CLIN ONCOL, V23, p636S

[4] Phase II trial of pemetrexed disodium (ALIMTA®, LY231514) in chemotherapy-naive patients with advanced non-small-cell lung cancer [J].

Clarke, SJ ;

Abratt, R ;

Goedhals, L ;

Boyer, MJ ;

Millward, MJ ;

Ackland, SP .

ANNALS OF ONCOLOGY, 2002, 13 (05) :737-741

[5]

CURRAN WJ, 2003, J CLIN ONCOL, V21, P621

[6] Metastases from non-small cell lung cancer: Mediastinal staging in the 1990s - Meta-analytic comparison of PET and CT [J].

Dwamena, BA ;

Sonnad, SS ;

Angobaldo, JO ;

Wahl, RL .

RADIOLOGY, 1999, 213 (02) :530-536

[7] The impact of regional nodal radiotherapy (dose/volume) on regional progression and survival in unresectable non-small cell lung cancer: an analysis of RTOG data [J].

Emami, B ;

Mirkovic, N ;

Scott, C ;

Byhardt, R ;

Graham, MV ;

Andras, EJ ;

John, M ;

Herskovic, A ;

Urtasun, R ;

Asbell, SO ;

Perez, CA ;

Cox, J .

LUNG CANCER, 2003, 41 (02) :207-214

[8] Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer [J].

Furuse, K ;

Fukuoka, M ;

Kawahara, M ;

Nishikawa, H ;

Takada, Y ;

Kudoh, S ;

Katagami, N ;

Ariyoshi, Y .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) :2692-2699

[9]

Gandara David R, 2003, J Clin Oncol, V21, P2004, DOI 10.1200/JCO.2003.04.197

[10] Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy [J].

Hanna, N ;

Shepherd, FA ;

Fossella, FV ;

Pereira, JR ;

De Marinis, F ;

von Pawel, J ;

Gatzemeier, U ;

Tsao, TCY ;

Pless, M ;

Muller, T ;

Lim, HL ;

Desch, C ;

Szondy, K ;

Gervais, R ;

Shaharyar ;

Manegold, C ;

Paul, S ;

Paoletti, P ;

Einhorn, L ;

Bunn, PA .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (09) :1589-1597

← 1 2 3 →